(19)
(11) EP 1 214 332 A1

(12)

(43) Date of publication:
19.06.2002 Bulletin 2002/25

(21) Application number: 00963540.0

(22) Date of filing: 16.09.2000
(51) International Patent Classification (IPC)7C07H 19/10, C07H 19/20, C12Q 1/68, G01N 33/53, A61K 31/7052, A61P 31/12
(86) International application number:
PCT/US0025/433
(87) International publication number:
WO 0119/841 (22.03.2001 Gazette 2001/12)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 17.09.1999 US 154739 P

(71) Applicant: Amersham Biosciences Corp.
Piscataway, N.J. 08855-1327 (US)

(72) Inventors:
  • KUMAR, Shiv
    Belle Mead, NJ 08502 (US)
  • FLICK, Parke
    Ringoes, NJ 08551 (US)
  • NELSON, John
    Neshanic Station, NJ 08853 (US)
  • FINN, Patrick
    Belle Mead, NJ 08502 (US)
  • NAMPALLI, Satayam
    Belle Mead, NJ 08502 (US)
  • BULL, Matthew
    Piscataway, NJ 08855 (US)

(74) Representative: Rollins, Anthony John et al
Amersham plcThe Grove CenterWhite Lion Road
AmershamBuckinghamshire HP7 9LL
AmershamBuckinghamshire HP7 9LL (GB)

   


(54) CHARGE-MODIFIED NUCLEIC ACID TERMINATORS